Chrome 2001
.
The Trusted Source InteliHealth Aetna InteliHealth Aetna InteliHealth
Enter Drug Name . Enter Search Term
     
. .
. .
.
Home
Health Commentaries
InteliHealth Dental

Ask the Expert
Interactive Tools
Todays News
InteliHealth Policies
Site Map
Diseases & Conditions Healthy Lifestyle Your Health Look It Up
Drug Resource Center Free E-Mail
.
. .
. .

Medications Headlines

LONDON (AP) -- Some advanced lung cancer patients already treated with chemotherapy might be able to skip some of the bad side effects of another series of chemo by taking a pill instead, a study suggests. An international study showed patients on Iressa, an expensive, newer targeted treatment, survived about as long as those on another course of chemotherapy.

(The New York Times News Service) -- When Italian researchers published a small study in February saying that lithium, a medication used to treat bipolar disorder, appeared to slow the progression of Lou Gehrig's disease, others with the devastating neurodegenerative disorder began to try it themselves. They did not have years to wait for a more conclusive study.

ATLANTA (AP) -- For the first time, an expensive vaccine aimed at preventing cervical cancer in women has proven successful at preventing a disease in men, according to a study released Thursday by the vaccine's maker. The disease is genital warts -- sexually transmitted, embarrassing and uncomfortable -- but not life-threatening.

WASHINGTON (AP) -- Scientists have pinpointed the molecular on-off switch that the powerful drug tamoxifen uses to attack breast cancer and which prevents it from working in some women.

NEW ORLEANS (AP) -- The controversial diabetes pill Avandia failed to significantly slow plaque buildup in heart arteries compared with an older drug, though there were some hopeful signs in a new study reported Wednesday.

NEW YORK (AP) -- Stent patients who take the blood thinner Plavix along with certain heartburn drugs may face a greater risk of heart attack, stroke and other dangerous events, according to a study released Tuesday.

JOHANNESBURG, South Africa (AP) -- Researchers trying to create the world's first malaria vaccine are launching a massive medical trial as early as next month involving 16,000 children that could be the largest such trial ever conducted on children in Africa.

News brought to you by:
Return to NYTimes Online Associated Press

.
InteliHealth
. . . .
.
More News
InteliHealth .
.
Top News
General Health
This Week In Health
Addiction
Allergy
Alzheimer's
Asthma
Arthritis
Babies
Breast Cancer
Cancer
Caregiving
Cervical Cancer
Children's Health
Cholesterol
Complementary & Alternative Medicine
Dental / Oral Health
Depression
Diabetes
Ear, Nose And Throat
Eyes
Family Health
Fitness
Headache
Heart Health
HIV / AIDS
Infectious Diseases
Lung Cancer
Medications
Men's Health
Mental Health
Nutrition News
Multiple Sclerosis
Nutrition Guide
Parkinson's
Pregnancy
Prevention
Prostate Cancer
Senior Health
Sexual / Reproductive Health
Sleep
Tobacco Cessation
STDs
Stress Reduction
Stroke
Weight Management
Today In Health History
Women's Health
Workplace Health
.
.
.
.
InteliHealth

   
.
.   HONcode
.
Chrome 2001
Chrome 2001